PTU-associated vasculitis in a girl with Turner Syndrome and Graves' disease
Department of Pediatrics
Antithyroid Agents; Child; Female; Graves Disease; Humans; Propylthiouracil; Thyroxine; Turner Syndrome; Vasculitis
Endocrinology, Diabetes, and Metabolism | Pediatrics
Palpable purpura is a concerning clinical finding in pediatric patients and can have many causes, including infectious and autoimmune processes. A rare cause, drug-induced vasculitis, may result from the production of antineutrophil cytoplasmic antibodies (ANCAs) in response to a medication. We report a girl with Turner syndrome and Graves' disease who presented with palpable purpuric lesions. The diagnosis of propylthiouracil (PTU)-associated vasculitis was made by observation of consistent clinical features, the detection of elevated ANA and ANCA in the blood, and the observed clinical resolution of symptoms following withdrawal of PTU. Subsequent treatment of persistent hyperthyroidism with radioablation did not result in an exacerbation of the vasculitis, a complication described in prior case reports.
Pediatr Emerg Care. 2006 Jan;22(1):52-4. Link to article on publisher's website
Pediatric emergency care
Hardy OT, Smolinski KN, Yan AC, Grimberg A. (2006). PTU-associated vasculitis in a girl with Turner Syndrome and Graves' disease. Endocrinology/Diabetes. Retrieved from https://escholarship.umassmed.edu/peds_endocrinology/8